ZAQS.ORG

Thursday, November 19, 2026 2:14 PM ET

CNBC - Health

Novartis raises blockbuster drug forecasts to $18 billion as it seeks to prove growth can last

9 hours ago

How this hedge fund is betting on people's fears of getting old

10 hours ago

How the FDA built a case against executives promising cheap medications

10 hours ago

Hims & Hers launches new slate of peptide treatments

21 hours ago

A generational flight from tech to defensive stocks is underway. How we're capitalizing

1 day ago

U.S. officially loses measles elimination status amid ongoing outbreaks

2 days ago

Novo says Wegovy injection lowers BMI and obesity rates in children in trial

3 days ago

Feds arrest top healthcare company official, alleging illegal drug importation

3 days ago

Measles is surging in the U.S. — and outbreaks can cost millions

8 days ago

FDA warns of vision loss risk linked to GLP-1 drugs like Wegovy, Zepbound

8 days ago

Eli Lilly's obesity pill eases sleep apnea in late-stage trial

9 days ago

Could supplements be the next big opportunity in the GLP-1 weight-loss drug boom?

10 days ago

Could CRISPR cure rare diseases before birth? Scientists are getting closer

8 days ago

Moderna hikes 2026 sales growth outlook, smashes quarterly estimates

8 days ago

Jim Cramer says the AI trade is not going away as Nasdaq enters correction

14 days ago

CVS Health plans to split itself up. Here's why a breakup could make sense now

14 days ago

Jim Cramer says this bank stock is a buy after its post-election pullback

15 days ago

CVS falls on plans to split off drugstore business in major breakup

15 days ago

Novo shares jump as Wegovy pill sales impress, drugmaker hikes outlook

15 days ago

Pfizer hikes 2026 outlook as new products grow, taps company veteran as new CFO

15 days ago

Midterm elections could jolt stocks as Democrats look poised to sweep Congress

15 days ago

A biotech's high-stakes cancer bet just paid off and its shares doubled

16 days ago

Jim Cramer says lower oil prices are giving stocks a boost. Can it last?

16 days ago

Stocks started the week higher but ended in despair. Our take on the big reversal

16 days ago

Cramer's week ahead: Expect more volatility as tech earnings, midterms loom

19 days ago

Gen Z is ditching bars for run clubs — and finding more than friends along the way

20 days ago

A pharma major is touting an MS drug to ease patent-cliff fears

20 days ago

West Pharma: More than a GLP-1 play. The case for further upside

20 days ago

Cramer sees opportunity amid tech turmoil and predicts a holiday win for FedEx

21 days ago

Merck tops estimates, hikes profit outlook on strength of injectable Keytruda

21 days ago

Eli Lilly blows past estimates, hikes sales outlook on resilient GLP-1 demand

21 days ago

GLP-1 coverage is shrinking for 2027. Here are weight-loss options for workers

21 days ago